The Growth of High Content Analysis Systems Market

High content analysis systems are also known as cellomics or high-content screening, is a method that is used in biological research to identify substances such as peptides, small molecules and other related substances. Further, it can be used for preclinical drug discovery pipeline such as companion diagnostics and to identify and validate new drug target to predict in vivo toxicity.

Besides, high content analysis systems allow a researcher to measure many features of organism once as compared to traditional high content analysis systems which has a single read out activity. In addition, various techniques such as automated imaging and fluorescent microscopic imaging are used to investigate cellular events such as cell viability, GPCR activity, apoptosis and many others.

This, in turn, is expected to increase the demand for high content analysis systems.

The factors which are driving the growth of high content analysis systems market are due to increasing growth in cellular research and drug analysis. According to the California Biomedical Research Association (CBRA), only 10%, of the drugs that initiate preclinical testing constantly and out of these five, only one is approved for human usage.

In addition, application such as cell cycle analysis, apoptosis, angiogenesis and others are anticipated to increase the demand for high content analysis systems. Further, increasing technological advancement such as imageXpress Pico, automated cell imaging system and ImageXpress Nano which are an ideal for cell counting and autophagy respectively. This, in turn, is expected to increase the growth of high content analysis systems market.

However, due to increased-cost of high content analysis system instruments and the dearth of knowledgeable for the operational of high-content analysis system instruments are expected to hamper the growth of high content analysis systems market.

Rapid increase in corona virus all around the world is expected to hamper the growth of high content analysis systems market. The virus outburst has become one of the threats to the global economy and financial markets.

The impact has made immense decrease in revenue generation in the field of all healthcare industry growth for the market in terms of compatibility and it has led in huge financial losses and human life which has hit very hard to the core of developing as well as emerging economies in healthcare sector.

It further anticipated that such gloomy epidemiological pandemic environment is going to remain in next for at least some months, and this is going to also affect the life-science market which also include the market of high content analysis systems market.

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Get FREE Report Sample

Market Segmentation

Based on the Products Type	Services Software’s Accessories Instruments Cell imaging and Analysis Systems Flow Cytometers Cell Analyzers Cell Sorters Consumables Reagent and Assay Kits Microplates Other Consumables
Based on the Technology	Flow Cytometry Microscopy Western Blotting ELISA Mass Spectrometry Others
Based on the Applications	Medical Applications Research Applications Immunology Research Stem Cells Research Other Research Applications
Based on the End User	Pharmaceutical and Biotechnology Companies Academic and Government Institutes Contract Research Organizations (CROs)

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

Get a Customized Version

Key Players

Some of the major key players competing in the global high content analysis systems market are Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, BioTek Instruments Inc., Yokogawa Electric Corporation, Danaher Corporation, GE Healthcare, Tecan Group Ltd., Perkinelmer, Inc. and Merck Millipore.